Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2015 Nov;78(5):498-504.
doi: 10.1038/pr.2015.152. Epub 2015 Aug 13.

Serum eotaxin-1 is increased in extremely-low-birth-weight infants with bronchopulmonary dysplasia or death

Affiliations
Observational Study

Serum eotaxin-1 is increased in extremely-low-birth-weight infants with bronchopulmonary dysplasia or death

Jegen Kandasamy et al. Pediatr Res. 2015 Nov.

Abstract

Background: Early systemic inflammation in extremely-low-birth-weight (ELBW) infants is associated with an increased risk of bronchopulmonary dysplasia (BPD). Our objective was to identify circulating biomarkers and develop prediction models for BPD/death soon after birth.

Methods: Blood samples from postnatal day 1 were analyzed for C-reactive protein (CRP) by enzyme-linked immunosorbent assay and for 39 cytokines/chemokines by a multiplex assay in 152 ELBW infants. The primary outcome was physiologic BPD or death by 36 wk. CRP, cytokines, and clinical variables available at ≤24 h were used for forward stepwise regression and Classification and Regression Tree (CART) analysis to identify predictors of BPD/death.

Results: Overall, 24% developed BPD and 35% died or developed BPD. Regression analysis identified birth weight and eotaxin (CCL11) as the two most significant variables. CART identified FiO2 at 24 h (11% BPD/death if FiO2 ≤28%, 49% if >28%) and eotaxin in infants with FiO2 > 28% (29% BPD/death if eotaxin was ≤84 pg/ml; 65% if >84) as variables most associated with outcome.

Conclusion: Eotaxin measured on the day of birth is useful for identifying ELBW infants at risk of BPD/death. Further investigation is required to determine if eotaxin is involved in lung injury and pathogenesis of BPD.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest/Financial Disclosures: There are no conflicts of interest or financial disclosures (other than funding as stated above) for any of the authors.

Figures

Figure 1
Figure 1
Serum eotaxin concentrations on postnatal day 1, comparing ELBW infants who survived without BPD to infants who died or develop BPD. Box and whiskers plot indicates median, 25th-75th centiles (lower and upper borders of box), 5th-95th centiles (lower and upper whiskers) and outliers (black dots). *p<0.05 versus “No BPD” group.
Figure 2
Figure 2
Classification and regression tree model for BPD/death by 36 weeks' post-menstrual age. The percentage of BPD/death at each node is indicated in bold font.
Figure 3
Figure 3
Absolute eosinophil counts on postnatal day 1 in infants who survived without BPD, compared to those who died or developed BPD (mean ± SEM; *p<0.05 versus “No BPD” group).

References

    1. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007;196:147.e141–148. - PubMed
    1. Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics. 2009;123:1562–1573. - PubMed
    1. Check J, Gotteiner N, Liu X, et al. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. J Perinatol. 2013;33:553–557. - PMC - PubMed
    1. Koksal N, Kayik B, Cetinkaya M, et al. Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants. Eur Cytokine Netw. 2012;23:29–35. - PubMed
    1. Munshi UK, Niu JO, Siddiq MM, Parton LA. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol. 1997;24:331–336. - PubMed

Publication types

MeSH terms